We are live on
!
Find out more
Harmony Biosciences
HRMY
HRMY
296 hedge funds and large institutions have $1.3B invested in Harmony Biosciences in 2025 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 116 increasing their positions, 88 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
244% more call options, than puts
Call options by funds: $30.8M | Put options by funds: $8.95M
69% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 26
32% more repeat investments, than reductions
Existing positions increased: 116 | Existing positions reduced: 88
6% more funds holding
Funds holding: 279 → 296 (+17)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
6.87% less ownership
Funds ownership: 89.25% → 82.38% (-6.9%)
20% less capital invested
Capital invested by funds: $1.62B → $1.3B (-$316M)
Holders
296
Holders Change
+17
Holders Change %
+6.09%
% of All Funds
3.89%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
44
Increased
116
Reduced
88
Closed
26
Calls
$30.8M
Puts
$8.95M
Net Calls
+$21.9M
Net Calls Change
+$13.6M
Top Buyers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$13.4M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$11.8M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$9.02M |
| 4 |
BA
Bridgewater Associates
Westport,
Connecticut
|
+$7.29M |
| 5 |
Renaissance Technologies
New York
|
+$7.15M |
